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Introduction
The pathophysiology of bipolar disorder is not fully understood. Genetics, circadian rhythms, neurotransmitters, psychosocial factors including childhood traumas, and neuroanatomic changes were blamed in the etiology [1, 2] . Accumulative evidence indicates that immune system dysfunction may play a role in the pathophysiology. Elevated levels of proinflammatory cytokines were detected in bipolar disorder [3] . The role of inflammation in mental disorders is not fully established, however, the connection between neurotransmitters and inflammation was shown. Proinflammatory cytokines interact with each other and neurotransmitters in the central nervous system via the cytokine network [4] . The neurotransmitter metabolism changes neuroendocrine function, synaptic plasticity, and related motor activity. These inflammatory cytokines could affect almost all aspects of brain function related to motivational behavior. These effects of the immune system in the brain could cause behavioral consequences and neuropsychiatric disorders [4] .
One of the determinants of chronic inflammation is the number of white blood cells and subtypes. The neutrophil/lymphocyte ratio (NLR) is a new parameter indicating systemic inflammatory response [5] [6] [7] .
Recently, platelet/lymphocyte and lymphocyte/monocyte ratios have been used to determine inflammation [8, 9] . It has been reported that NLR and platelet/lymphocyte ratio (PLR), which are subclinical inflammatory markers, are increased in bipolar disorder [10] .
Electroconvulsive therapy (ECT) is effective and safe in all manic, depressive, and mixed stages of bipolar disorder [11] . It is a frequently preferred method of treatment for inpatients [12] . Acute immune-inflammatory response increases as an acute stress reaction immediately after ECT sessions. However, after repeated ECT, the inflammatory response decreases at the end of the treatment process [13] .
In this study, we report the results of our research on subclinical inflammatory markers, namely, NLR and PLR, and the improvement of symptoms after ECT in patients with bipolar disorder in manic and depressive stages.
Materials and methods
Patients who received ECT due to the diagnosis of bipolar disorder according to DSM-5 in the last two years in the Psychiatry Department of Gaziantep University, Faculty of Medicine and the same number of individuals as the control group were included in this case-control study. Ethics committee approval was obtained from Gaziantep University Clinical Studies Ethics Council (2018/360). 112 patients had undergone ECT for bipolar disorder in the last two years. Patients with severe neurological diseases, diabetes mellitus and other endocrinopathies, liver diseases, malignancies, intellectual disability, alcohol, substance use disorder or addiction history were excluded from the study. Among the remaining 63 bipolar patients in remission in the depression (HAMD<7) and manic (YMRS <12) phases, 11 patients were excluded due to lack of a complete blood count. Among the 52 included, 39 had depressive bipolar and 13 had manic bipolar disorder. Those who had no complaints in the 15 days following ECT (n=52) were identified as the study group. Prior to ECT, all patients had completed evaluations for anesthesia and did not have any active infections. The control group was selected from the last 52 healthy individuals without any disabilities, based on the report issued by the psychiatric outpatient clinic after general screening in the last six months. Sociodemographic variables such as age and gender of the patients were recorded.
ECT was administered bilaterally under general anesthesia after administration of 1 mg/kg propofol seven times a week, on Monday, Wednesday, and Friday at 800 mA with MECTA 5000Q ECT, allowing the patients to have seizures for a period of 30-60 seconds. Patients continued to use additional medication at the beginning of the study. Among 39 patients with bipolar depressive episode, 10 were using lamotrigine, 16 were using valproate, and 6 were using lithium. Five patients were using antidepressants in addition to mood stabilizers. Seven patients who did not use mood stabilizers had quetiapine in their combination. All of 13 the bipolar manic patients were on antipsychotics. 4 of them were using lithium and 4 of them were using valproate in combination with antipsychotics. Four patients with bipolar manic episode had discontinued their medication, and emergency hospitalization had been planned due to manic episode. Haloperidol, biperiden, chlorpromazine injections and additional antipsychotics were used for the treatment of these patients for 3 days and ECT was administered due to exacerbation. They continued to take antipsychotics orally during ECT. There were no patients who did not receive any medication.
52 patients and 52 healthy control individuals were compared in terms of NLR and PLR before and after ECT.
Statistical analysis
Descriptive statistics for demographic characteristics were used to evaluate the data of the patient group. χ2 test was used to compare categorical variables. T-test was used to compare normally distributed variables, and paired t-test was used for the pre-ECT and post-ECT comparisons of NLR and PLR. Data were analyzed with SPSS v24.0 (IBM Corporation York, United States) for Windows.
Results
The mean age of the patients was 36.05 (13.4) years. The average duration of education was 6.40 (3.5) years. The bipolar patient group consisted of 25 men and 27 women. No significant difference was found between healthy controls and patients in terms of age, sex, marital status, or smoking (Table  1 ). NLR values were significantly higher in patients with bipolar disorder than the control group before ECT (P<0.001). PLR did not differ between healthy and control groups ( Table 2) . After ECT, NLR remained significantly higher in the patient group than in the controls (P=0.003). There was no difference in PLR values ( Table 2 ). No significant difference was found P a g e / S a y f a | 795 between NLR and PLR in the pre-ECT and post-ECT evaluation ( Table 3) , and depressive and manic episodes. 
Discussion
The first finding of our study was that NLR was higher in patients with bipolar disorder who were on medication than healthy controls. Studies support the role of inflammation in bipolar disorder [3] . The prevalence of bipolar disorder has been shown to increase in patients with autoimmune disorders, cardiovascular diseases, and metabolic dysfunction [14] . Interleukin IL-4, IL-6, IL-10, soluble IL-2 receptor concentrations, tumor necrosis factor (TNF) -alpha, and soluble TNF receptor-1 were significantly higher in patients in the manic and euthymic periods compared to healthy controls [15] . TNFalpha and IL-6 were found to increase in bipolar depressive period [16, 17] . In another study, inflammation was reported as an important predictor of relapse in the course of bipolar disorder, especially during the depressive period [18] . Neutrophillymphocyte and platelet-lymphocyte ratios were significantly higher in bipolar disorder in both manic and euthymic patients than in the control group [10] . Our study, in which we found that the NLR values of patients using drugs due to bipolar disorder were higher, also supports these findings.
There were a few studies investigating the effect of ECT on the inflammatory system. More studies are focused on the alteration of inflammatory markers in the treatment of major depression in ECT [19, 20] . In our literature review, we could not find a study directly investigating the effect of ECT on NLR and PLR in bipolar disorder. In a study which examined oxidant levels, total antioxidant levels increased with ECT in depressive bipolar patients, and total oxidant levels decreased in manic patients [21] . As an anti-inflammatory agent, celecoxib did not significantly affect BDNF level or treatment response after ECT in bipolar manic patients [22] . In our study, there was no significant alteration in NLR or PLR after ECT.
The retrospective design of the study, the scarce number of patients and the lack of the evaluation of body mass index were the limitations of our study. However, studies investigating the body mass index in relation to inflammation found a very low correlation [23] . Another limitation of the study was that patients were taking various medications. However, the inclusion of antidepressants in complex therapy is thought to alleviate chronic inflammation [24] . Studies reporting that mood regulators decrease inflammatory markers are dominant in the literature [25, 26] . There was no significant relationship between antipsychotic use and inflammatory markers [27] .
This study demonstrates the presence of subclinical inflammation in bipolar disorder, which continues after ECT. To determine the effects of ECT on inflammation, further studies are needed in large-scale patient groups who do not use drugs.
